Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cholylglycine
2. Glycine Cholate
3. Glycocholate
4. Glycocholate Sodium
5. Glycocholic Acid
6. Glycocholic Acid, Sodium Salt
1. 863-57-0
2. Glycocholic Acid Sodium Salt
3. Glycocholate Sodium
4. Glycocholate Sodium Salt
5. Monosodium Glycocholic Acid
6. Glycocholic Acid, Sodium Salt
7. V06cxa1w3k
8. Sodium Glycocholate Hydrate
9. Glycocholic Acid (sodium)
10. Nsc-35609
11. Unii-v06cxa1w3k
12. Sodium N-(3-alpha,7-alpha,12-alpha-trihydroxy-24-oxocholan-24-yl)glycinate
13. Sodium Glycylcholate
14. Einecs 212-730-9
15. Nsc 35609
16. Glycine, N-choloyl-, Monosodium Salt
17. N-cholylglycine Sodium Salt
18. Sodium Cholylglycinate
19. Monosodium Glycocholate
20. Glycocholicacidsodiumsalt
21. Chebi:36273
22. Hy-n1423a
23. N-choloylglycine, Monosodium Salt
24. Dtxsid001349031
25. Mfcd00036741
26. Akos025286001
27. As-59333
28. Cs-0016853
29. G0207
30. S-4700
31. Q27116768
32. Sodium N-(3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oyl)glycinate
33. Glycine, N-((3.alpha.,5.beta.,7.alpha.,12.alpha.)-3,7,12-trihydroxy-24-oxocholan-24-yl)-, Sodium Salt (1:1)
34. Glycine, N-((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)-, Monosodium Salt
35. Sodium;2-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate
| Molecular Weight | 487.6 g/mol |
|---|---|
| Molecular Formula | C26H42NNaO6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 487.29098234 g/mol |
| Monoisotopic Mass | 487.29098234 g/mol |
| Topological Polar Surface Area | 130 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 766 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Cholagogues and Choleretics
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)
Detergents
Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)
Digital Content 
DATA COMPILATION #PharmaFlow
Market Place
ABOUT THIS PAGE
24
PharmaCompass offers a list of Sodium Glycocholate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycocholate manufacturer or Sodium Glycocholate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycocholate manufacturer or Sodium Glycocholate supplier.
PharmaCompass also assists you with knowing the Sodium Glycocholate API Price utilized in the formulation of products. Sodium Glycocholate API Price is not always fixed or binding as the Sodium Glycocholate Price is obtained through a variety of data sources. The Sodium Glycocholate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Glycocholate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Glycocholate, including repackagers and relabelers. The FDA regulates Sodium Glycocholate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Glycocholate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Glycocholate supplier is an individual or a company that provides Sodium Glycocholate active pharmaceutical ingredient (API) or Sodium Glycocholate finished formulations upon request. The Sodium Glycocholate suppliers may include Sodium Glycocholate API manufacturers, exporters, distributors and traders.
Sodium Glycocholate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Glycocholate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Glycocholate GMP manufacturer or Sodium Glycocholate GMP API supplier for your needs.
A Sodium Glycocholate CoA (Certificate of Analysis) is a formal document that attests to Sodium Glycocholate's compliance with Sodium Glycocholate specifications and serves as a tool for batch-level quality control.
Sodium Glycocholate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Glycocholate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Glycocholate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Glycocholate EP), Sodium Glycocholate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Glycocholate USP).
